Navigation Links
Monsanto Recognized as Top Biotechnology Employer by Science Magazine
Date:10/9/2008

Company climbs to No. 2 in ranking; up six spots from last year

ST. LOUIS, Oct. 9 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) is earning recognition as a leader in biotechnology not just for its ground-breaking products but also for being a great place to work.

Monsanto, headquartered in St. Louis, Missouri, took second place in the 2008 Top Biotech and Pharma Employers list by Science, a leading industry publication. The company moved up six spots from number eight the prior year. The annual web-based survey rates companies around the world in 23 categories. The top driver in the survey was being an innovative leader in the industry, followed by quality of top management, and loyal employees, said Ian King, associate director of science careers for Science magazine.

"More than 90 percent of the respondents who voted for Monsanto agreed that each of those attributes applied to the organization, up from 70 percent in last year's survey," King said. "That's a massive increase."

Monsanto is dedicated to delivering innovative solutions to farmers that help them be more productive and profitable, as well as health benefits to consumers through better, and more nutritious foods, said Robert T. Fraley, Ph.D., chief technology officer and executive vice president for the company.

"I am thrilled that Monsanto is being recognized as a great place for cutting-edge research. Making new discoveries starts with having a terrific team. Our scientists and researchers play a key role in the company's success," Fraley said. "The work they are doing today will help us meet our goal of doubling yields by 2030 while conserving more of the world's resources."

The survey also included such categories as corporate image, work environment, work/life balance, and compensation and benefits. Monsanto ranked second only to San Francisco-based Genentech Inc.

Monsanto was recently honored as one of the 2008 Working Mother 100 Be
'/>"/>

SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Monsanto Company Signs Share Subscription Agreement With Devgen
3. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
4. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
5. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
6. Science Magazine Recognizes Monsanto as Top Employer
7. Monsanto Company Executives Adopt 10b5-1 Trading Plans
8. Monsanto and Devgen Describe New Approach to Insect-Protection
9. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
10. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
11. Monsanto Executives to Address Investor Conferences in February
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. ... announced today that they have been acquired by Roche ... is a privately held company that provides a big ... generation sequencing (NGS) data for the academic and translational ... Sequencing Unit, and will continue to focus on development ...
(Date:12/19/2014)... December 18, 2014 Today, ... its pilot production facility and future company headquarters ... produce innovative new materials that safely and effectively ... only because of its historic, strong support for ... to attract leading edge, technology-based companies such as ...
(Date:12/19/2014)... iLab Solutions, the global leader in ... Bryant as the new Director of Institutional Implementations and ... These two new leadership positions were created to support ... that iLab continues to meet the needs of its ... iLab has been deployed at over 450 core facilities ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... President, Operations and Chief Financial Officer ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... Calif., Nov. 5, 2010 Clarient, Inc. (Nasdaq: ... unanimously agreed to recommend that Clarient stockholders tender their shares ... the previously announced price of $5.00 per share of Clarient,s ... Convertible Preferred Stock. The transaction is expected to ...
Cached Biology Technology:OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 2OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 3OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 4OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 5OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 6OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 7OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 8OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 9Study Shows Cardiovascular Deaths in Europe Could Be Prevented 2Study Shows Cardiovascular Deaths in Europe Could Be Prevented 3Study Shows Cardiovascular Deaths in Europe Could Be Prevented 4Study Shows Cardiovascular Deaths in Europe Could Be Prevented 5Study Shows Cardiovascular Deaths in Europe Could Be Prevented 6Study Shows Cardiovascular Deaths in Europe Could Be Prevented 7Study Shows Cardiovascular Deaths in Europe Could Be Prevented 8Study Shows Cardiovascular Deaths in Europe Could Be Prevented 9Study Shows Cardiovascular Deaths in Europe Could Be Prevented 10Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 2Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 3Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 4
(Date:12/22/2014)... 2014 Research and Markets ... of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... of the global digital media watermarking and ... monitor piracy by securely and invisibly embedding ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics ... pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred ... has served as a meeting place for peoples from ... the ongoing mixing of peoples with African, European, and ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... brain development in infants and detect disturbances in white ... of Radiology. , Carola van Pul, Ph.D., and colleagues ... seven normal infants and 10 infants with perinatal hypoxic ... period of oxygen and nutrient deficiency, usually as a ...
... immediate pain of the bite is followed by swelling, ... nausea, blurred vision and possibly convulsions before it's all ... brew of toxins in snake venom. , It's long ... than reducing the symptoms, may make things worse. But ...
... study shows motion and door sensors placed in elders' ... to memory changes that are early signs of dementia. ... 10th International Conference on Alzheimer's Disease and Related Disorders ... activity may be a reliable way of assessing changes ...
Cached Biology News:New tool tracks brain development in babies 2Stanford snake venom study shows that certain cells may eliminate poison 2Stanford snake venom study shows that certain cells may eliminate poison 3Stanford snake venom study shows that certain cells may eliminate poison 4In-home sensors spot dementia signs in elderly 2In-home sensors spot dementia signs in elderly 3
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis....
Loading Buffer...
Request Info...
Request Info...
Biology Products: